Topical Cocaine Provides US FDA With First Case Of ‘Dueling’ 505(b)(2) NDAs

 
• By Bridget Silverman
  
Wild-west-duel
The FDA is not aware of another set of ‘dueling’ 505(b)(2) applications since 1984." • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from United States

More from North America